Rasagiline

Rasagiline
Rasagail is a medication that belongs to the class of drugs known as monoamine oxidase type B (MAO-B) inhibitors. Rasagail is used to treat the symptoms of Parkinson's disease, a neurological disorder that affects movement and muscle control.
Rasagail works by inhibiting the activity of the MAO-B enzyme, which is responsible for breaking down dopamine, a neurotransmitter that is important for regulating movement and other functions in the brain. By blocking the breakdown of dopamine, Rasagail can help to increase dopamine levels in the brain and improve Parkinson's disease symptoms.
Rasagail is typically taken orally, once daily, with or without food. It may be used alone or in combination with other medications used to treat Parkinson's disease.
As with any medication, Rasagail can cause side effects, including headache, dizziness, dry mouth, constipation, and insomnia. It may also increase the risk of developing serotonin syndrome, a potentially life-threatening condition that can occur when there is an excessive accumulation of serotonin in the body.
It is important to talk to your healthcare provider about any concerns or questions you may have about taking Rasagail and to follow their instructions carefully. Additionally, Rasagail should not be stopped suddenly without the guidance of a healthcare provider, as this can lead to withdrawal symptoms.
Rasagail is available in strengths of 0.5,1 and 2 mg.
For further information please contact:
info@sterispharma.com